XEM:CA:TSX-iShares MSCI Emerging Markets Index ETF (CAD)

ETF | Emerging Markets Equity |

Last Closing

CAD 35.07

Change

+0.68 (+1.98)%

Market Cap

CAD 0.20B

Volume

0.11M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Emerging Markets Equity

Symbol Name Price(Change) Market Cap
XSEM:CA iShares ESG MSCI Emerging Mark..

+0.57 (+2.63%)

CAD 3.24B
XEC:CA iShares Core MSCI Emerging Mar..

+0.54 (+1.80%)

CAD 1.80B
ZEM:CA BMO MSCI Emerging Markets Inde..

+0.53 (+2.35%)

CAD 1.07B
DRFE:CA Desjardins RI Emerging Markets..

+0.02 (+0.08%)

CAD 0.08B
XMM:CA iShares MSCI Min Vol Emerging ..

+0.01 (+0.03%)

CAD 0.06B
RXD:CA RBC Quant Emerging Markets Div..

+0.18 (+0.83%)

CAD 0.04B
VEE:CA Vanguard FTSE Emerging Markets

+0.82 (+2.10%)

N/A
ZLE:CA BMO Low Volatility Emerging Ma..

+0.26 (+1.30%)

N/A

ETFs Containing XEM:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Emerging Markets Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.04% 44% F 75% C
Dividend Return 0.59% 33% F 18% F
Total Return 19.63% 56% F 72% C
Trailing 12 Months  
Capital Gain 23.92% 44% F 62% D
Dividend Return 2.45% 71% C- 42% F
Total Return 26.37% 44% F 62% D
Trailing 5 Years  
Capital Gain 14.98% 44% F 47% F
Dividend Return 7.40% 40% F 26% F
Total Return 22.38% 56% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 1.06% N/A N/A 41% F
Dividend Return 2.61% N/A N/A 42% F
Total Return 1.55% N/A N/A 48% F
Risk Return Profile  
Volatility (Standard Deviation) 15.54% N/A N/A 72% C
Risk Adjusted Return 16.78% N/A N/A 39% F
Market Capitalization 0.20B 57% F 46% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike